United Kingdom

Covid-19 coronavirus: regulatory flexibility and the importance of collaboration in the UK

Megan McMellon

Regulatory flexibility Covid-19 coronavirus  has seen medical regulators across the globe take action in order to support the pandemic response effort.  In the UK, the Medicines and Healthcare Products Regulatory Agency (the MHRA) has worked with the Department of Health and Social Care and other stakeholders to identify where regulatory flexibilities are possible and guidance Read More

Covid-19 coronavirus: UK launches Future Fund to support fast-growth businesses

William Samengo-Turner

In what will undoubtedly be a relief for UK’s life science sector, the government yesterday unveiled the ways in which it plans to support the community of fast-growth businesses that drive so much innovation within its domestic market and around the world. Privately held UK businesses that have raised at least £250,000 in the last Read More

Mexichem UK Ltd v Honeywell International Inc [2020] EWCA Civ 473 – Will a broad Arrow declaration fly?

Rafi Allos

An Arrow declaration is a form of discretionary relief granted by UK courts declaring that a product or process would have lacked novelty, or been obvious, at a specific point in time.  In contrast to declarations of non-infringement, an Arrow declaration can, in certain circumstances, be sought to achieve commercial certainty in relation to a Read More

Podcast: How to protect IP as part of a digital transformation strategy

Nigel Parker

Digitalisation is transforming businesses at an ever-increasing rate.  No matter the sector, technologies like cloud computing, the Internet of Things, AI and Blockchain are enabling streamlining of operations, new distribution channels and better customer insights.  Digital transformation is also creating new strategic imperatives as “digital natives” take market share from traditional industries. Partners Mark Ridgway Read More

Evalve v Edwards – Review of competing public interests in grant of final injunctions

Marjan Noor

The issue of whether public interest considerations can be relied upon against the grant of a final injunction, or for a carve out in the injunction, is a very live one in disputes in relation to innovative medical devices and pharmaceuticals. In this decision, Edwards argued that, although its PASCAL product used to treat mitral Read More